These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 21922417

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Novel vasoconstrictor formulation to enhance intranasal targeting of neuropeptide therapeutics to the central nervous system.
    Dhuria SV, Hanson LR, Frey WH.
    J Pharmacol Exp Ther; 2009 Jan; 328(1):312-20. PubMed ID: 18945930
    [Abstract] [Full Text] [Related]

  • 3. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration.
    Thorne RG, Pronk GJ, Padmanabhan V, Frey WH.
    Neuroscience; 2004 Jan; 127(2):481-96. PubMed ID: 15262337
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Direct transport of VEGF from the nasal cavity to brain.
    Yang JP, Liu HJ, Cheng SM, Wang ZL, Cheng X, Yu HX, Liu XF.
    Neurosci Lett; 2009 Jan 09; 449(2):108-11. PubMed ID: 18996442
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Application of a hybrid computational fluid dynamics and physiologically based inhalation model for interspecies dosimetry extrapolation of acidic vapors in the upper airways.
    Frederick CB, Bush ML, Lomax LG, Black KA, Finch L, Kimbell JS, Morgan KT, Subramaniam RP, Morris JB, Ultman JS.
    Toxicol Appl Pharmacol; 1998 Sep 09; 152(1):211-31. PubMed ID: 9772217
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Intranasal drug targeting of hypocretin-1 (orexin-A) to the central nervous system.
    Dhuria SV, Hanson LR, Frey WH.
    J Pharm Sci; 2009 Jul 09; 98(7):2501-15. PubMed ID: 19025760
    [Abstract] [Full Text] [Related]

  • 16. Intranasal Drug Delivery: A Non-Invasive Approach for the Better Delivery of Neurotherapeutics.
    Kumar H, Mishra G, Sharma AK, Gothwal A, Kesharwani P, Gupta U.
    Pharm Nanotechnol; 2017 Jul 09; 5(3):203-214. PubMed ID: 28521670
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Modulation of brain delivery and copulation by intranasal apomorphine hydrochloride.
    Lu W, Jiang W, Chen J, Yin M, Wang Z, Jiang X.
    Int J Pharm; 2008 Feb 12; 349(1-2):196-205. PubMed ID: 17904315
    [Abstract] [Full Text] [Related]

  • 19. Nasal-associated lymphoid tissue and olfactory epithelium as portals of entry for Burkholderia pseudomallei in murine melioidosis.
    Owen SJ, Batzloff M, Chehrehasa F, Meedeniya A, Casart Y, Logue CA, Hirst RG, Peak IR, Mackay-Sim A, Beacham IR.
    J Infect Dis; 2009 Jun 15; 199(12):1761-70. PubMed ID: 19456230
    [Abstract] [Full Text] [Related]

  • 20. Transport of manganese via the olfactory pathway in rats: dosage dependency of the uptake and subcellular distribution of the metal in the olfactory epithelium and the brain.
    Henriksson J, Tallkvist J, Tjälve H.
    Toxicol Appl Pharmacol; 1999 Apr 15; 156(2):119-28. PubMed ID: 10198277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.